ITGAM and neoplasm: Evaluation of blood cells in tumor-bearing flt-1TK–/–/C57BL and C57BL mice showed no significant difference between circulating CD45+, CD11b+, Gr-1+, VEGFR1+ or CXCR4+ cells in these mice (Figure 3A).